Ascendis Pharma A/S EV/EBIT
¿Qué es el EV/EBIT de Ascendis Pharma A/S?
El EV/EBIT de Ascendis Pharma A/S es N/A
¿Cuál es la definición de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de compañías en Sector Health Care en NASDAQ en comparadas con Ascendis Pharma A/S
¿Qué hace Ascendis Pharma A/S?
ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.
Empresas con ev/ebit similar a Ascendis Pharma A/S
- Surface Transforms Plc tiene EV/EBIT de N/A
- Boqii Ltd tiene EV/EBIT de N/A
- Sunrun tiene EV/EBIT de N/A
- Mind Medicine (MindMed) tiene EV/EBIT de N/A
- Coveo Solutions tiene EV/EBIT de N/A
- Innovative Designs tiene EV/EBIT de N/A
- Ascendis Pharma A/S tiene EV/EBIT de N/A
- Biomerica tiene EV/EBIT de N/A
- Crescent NV tiene EV/EBIT de N/A
- Ivrnet tiene EV/EBIT de N/A
- Orion Office REIT tiene EV/EBIT de N/A
- Ansal Properties & Infrastructure tiene EV/EBIT de N/A
- Nanophase Technologies tiene EV/EBIT de N/A